Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study

被引:47
作者
Strawn, Jeffrey R. [1 ]
Adler, Caleb M. [1 ]
McNamara, Robert K. [1 ]
Welge, Jeffrey A. [1 ]
Bitter, Samantha M. [1 ]
Mills, Neil P. [1 ]
Barzman, Drew H. [2 ]
Cerullo, Michael A. [1 ]
Chang, Kiki D. [3 ]
Strakowski, Stephen M. [1 ]
DelBello, Melissa P. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Div Bipolar Disorders Res, Cincinnati, OH 45267 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Pediat Bipolar Disorders Program, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
anxiety disorders; bipolar disorder; major depressive disorder; mania; SSRI; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED-TRIAL; DOUBLE-BLIND; DIVALPROEX MONOTHERAPY; RESISTANT DEPRESSION; ANXIETY DISORDERS; MANIC SYMPTOMS; I DISORDER; ADOLESCENTS; CHILDREN;
D O I
10.1111/bdi.12113
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Depressive and anxiety disorders are common in youth who are at risk for bipolar disorder (i.e., youth who have at least one parent with bipolar disorder) and antidepressants are commonly prescribed as treatment. However, there are few data regarding the safety and tolerability of antidepressants in this population. Therefore, we sought to prospectively examine the effects of these medications in children and adolescents who are diagnosed with depressive or anxiety disorders and have a parent with bipolar I disorder. Methods: Youth aged 9-20 years, with at least one parent with bipolar I disorder [high risk (HR)], were recruited (n = 118) and assessed using semi-structured diagnostic interviews. Participants were prospectively evaluated using a modified version of the Longitudinal Interval Follow-up Evaluation to assess changes in affective and anxiety symptoms and were treated naturalistically. Results: Over the course of 43-227 weeks (mean duration of follow-up: 106 +/- 55 weeks), 21% (n = 25) of youth had antidepressant exposure and, of these, 57% (n = 12) had an adverse reaction (e. g., irritability, aggression, impulsivity, or hyperactivity) that led to antidepressant discontinuation. Those patients who experienced an adverse reaction were significantly younger than those who did not (p = 0.02) and discontinuation of antidepressant therapy secondary to an adverse event occurred at an average of 16.7 +/- 17.4 weeks (median: 11 weeks, range: 2-57 weeks). Cox proportional hazard analyses yielded a hazard ratio of 0.725 (p = 0.03), suggesting that there is a 27% decrease in the likelihood of an antidepressant-related adverse event leading to discontinuation with each one-year increase in age. Conclusions: Antidepressant medications may be poorly tolerated in youth with a familial risk for developing mania. Controlled studies further assessing treatments for depression and anxiety in HR youth are urgently needed.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 38 条
[1]   Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial [J].
Amminger, G. Paul ;
Schafer, Miriam R. ;
Papageorgiou, Konstantinos ;
Klier, Claudia M. ;
Cotton, Sue M. ;
Harrigan, Susan M. ;
Mackinnon, Andrew ;
McGorry, Patrick D. ;
Berger, Gregor E. .
ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (02) :146-154
[3]   A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene [J].
Baumer, Fiona M. ;
Howe, Meghan ;
Gallelli, Kim ;
Simeonova, Diana Lorgova ;
Hallmayer, Joachim ;
Chang, Kiki D. .
BIOLOGICAL PSYCHIATRY, 2006, 60 (09) :1005-1012
[4]   A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults [J].
Bechdolf, Andreas ;
Nelson, Barnaby ;
Cotton, Sue M. ;
Chanen, Andrew ;
Thompson, Andrew ;
Kettle, Jonathan ;
Conus, Phillippe ;
Amminger, G. Paul ;
Yung, Alison R. ;
Berk, Michael ;
McGorry, Patrick D. .
JOURNAL OF AFFECTIVE DISORDERS, 2010, 127 (1-3) :316-320
[5]   Practice parameter for the assessment and treatment of children and adolescents with depressive disorders [J].
Birmaher, Boris .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (11) :1503-1526
[6]   Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression - The TORDIA randomized controlled trial [J].
Brent, David ;
Emslie, Graham ;
Clarke, Greg ;
Wagner, Karen Dineen ;
Asarnow, Joan Rosenbaum ;
Keller, Marty ;
Vitiello, Benedetto ;
Ritz, Louise ;
Iyengar, Satish ;
Abebe, Kaleab ;
Birmaher, Boris ;
Ryan, Neal ;
Kennard, Betsy ;
Hughes, Carroll ;
DeBar, Lynn ;
McCracken, James ;
Strober, Michael ;
Suddath, Robert ;
Spirito, Anthony ;
Leonard, Henrietta ;
Melhem, Nadine ;
Porta, Giovanna ;
Onorato, Matthew ;
Zelazny, Jamie .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08) :901-913
[7]   Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms [J].
Chang, KD ;
Dienes, K ;
Blasey, C ;
Adleman, N ;
Ketter, T ;
Steiner, H .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (08) :936-942
[8]   Psychiatric phenomenology of child and adolescent bipolar offspring [J].
Chang, KKD ;
Steiner, H ;
Ketter, TA .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2000, 39 (04) :453-460
[9]   Review of the efficacy and safety of antidepressants in youth depression [J].
Cheung, AH ;
Emslie, GJ ;
Mayes, TL .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2005, 46 (07) :735-754
[10]   Antidepressant exposure in bipolar children [J].
Cicero, D ;
El-Mallakh, RS ;
Holman, J ;
Robertson, J .
PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 2003, 66 (04) :317-322